Piramal offers a fast-track early stage development service for your ADC programm. Whether you are selecting your candidate mAb, linker or toxin, we have a program that will meet your needs.

Speak to our
experts

Tailored to meet your needs

Cost-effective Proof-of-Concept conjugation service to demonstrate the viability of cytotoxic drugs or monoclonal antibodies for use as therapeutic ADCs.

Piramal's Core Strengths

  • Short lead times to start your projects
  • Competence to operate at mg-g scale for preparation of low endotoxin conjugates
  • Integrated Process and Analytical Development functions
  • Process development and scale-up to GMP manufacture

Customer Antibodies for Suitability for Conjugation

  • Comparison of different chemistries (cysteine, lysine)
  • Range of different linkers available (cleavable, non-cleavable, PEGylated)
  • Range of payloads available (microtubule disrupting drugs, DNA damaging compounds, protein ribosome inactivating toxins, chelators of radioimmunotherpy)
  • Preparation of different drug loadings
  • Analytical characterisation and screening of conjugates

Customer Cytotoxic or Linker Technologies

  • Piramal can make various conjugates with model antibodies using your linker or drug platforms
  • Experience with a range of novel linker technologies

ADC Standards to Benchmark Client Materials

  • Model antibody with DAR 2, DAR 4 with different ADC toxins

Other Offerings

Proof-of-Concept Preclinical Development Studies

Conjugation Process Development and Scale Up

Pre-clinical and Toxicology ADC Manufacture

ADC Clinical and Commercial Manufacturing

ADC Fill/Finish

Analytical Method Development Services

Bulk Drug Substance and Finished Product Release Testing

In vivo an Imaging services

Piramal offers a fast-track early stage development service for your ADC programmes. Whether you are selecting your candidate mAb, linker or toxin, we have a programme that will meet your needs. Tailored to perfection.

Piramal offers ADC process development and scale-up through Tox manufacture and into GMP manufacture. Our highly experienced team has been working on ADCs for over 10 years, working on over 130 different ADC candidates and over 40 different toxin/toxin-linker systems.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

World-leading multi-product facility for clinical and commercial manufacturing of antibody drug conjugates (ADCs). Process development. characterisation, optimisation and scale-up expertise supporting successful GMP manufacturing.

Piramal offers aseptic filling of ADC drug product through our FDA-approved state-of-the-art manufacturing facility in Lexington, KY. Our facility is centred around mobile isolator technology, providing an ISO 5 environment during processing, as well as product containment for potent and cytotoxic products.

Piramal's highly experienced Analytical Development team covers a wide range of analytical methods from small molecule analysis through to cell killing assays and ELISA development. All your analytical development and testing requirements on a single site.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

Great!